Jaguar Health Announces Approval of All Proposals at Special Stockholders Meeting

Jaguar Health, Inc. (NASDAQ: JAGX) revealed the outcomes of its Special Meeting of Stockholders held on April 20, 2026. All five proposals presented to the company's stockholders received approval. Detailed descriptions of these proposals can be found in the company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on March 24, 2026.

Stockholders interested in accessing these documents can do so for free through the SEC's website or Jaguar’s corporate site. The approval of these proposals marks a significant step for Jaguar Health as it continues its focus on developing proprietary prescription drugs derived from plants aimed at treating complex gastrointestinal diseases.